Literature DB >> 21238583

Receptor specific crosstalk and modulation of signaling upon heterodimerization between β1-adrenergic receptor and somatostatin receptor-5.

Rishi K Somvanshi1, Sajad A War, Nicole Chaudhari, Xiaofan Qiu, Ujendra Kumar.   

Abstract

In the present study we describe heterodimerization, trafficking, coupling to adenylyl cyclase and signaling in HEK-293 cells cotransfected with human-somatostatin receptor 5 (hSSTR5) and β(1)-adrenergic receptor (β(1)AR). hSSTR5/β(1)AR exists as heterodimers in basal conditions which was further enhanced upon synergistic activation of both receptors. Activation of either β(1)AR or hSSTR5 displayed dissociation of heterodimerization. In cotransfectants, β(1)AR effect on cAMP was predominant; however, blocking β(1)AR with antagonist resulted in 60% inhibition of forskolin-stimulated cAMP in the presence of hSSTR5 agonists. cAMP/PKA pathway in cotransfected cells was regulated in receptor-specific manner, in contrast, the status of pERK1/2 and pPI3K/AKT was predominantly regulated by hSSTR5. The expression levels of phosphorylated NFAT remained unchanged indicating blockade of calcineurin-mediated dephosphorylation and nuclear translocation of NFAT, the process predominantly regulated by pJNK in SSTR5 dependent manner. Taken together, the functional consequences of results described here might have relevance in the cardiovascular system where SSTR and AR subtypes play important roles.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21238583     DOI: 10.1016/j.cellsig.2011.01.002

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  8 in total

1.  Adenosine A1 receptors heterodimerize with β1- and β2-adrenergic receptors creating novel receptor complexes with altered G protein coupling and signaling.

Authors:  P Charukeshi Chandrasekera; Tina C Wan; Elizabeth T Gizewski; John A Auchampach; Robert D Lasley
Journal:  Cell Signal       Date:  2013-01-03       Impact factor: 4.315

Review 2.  Cross-talk and modulation of signaling between somatostatin and growth factor receptors.

Authors:  Ujendra Kumar
Journal:  Endocrine       Date:  2011-08-26       Impact factor: 3.633

3.  β1-adrenergic receptor and sphingosine-1-phosphate receptor 1 (S1PR1) reciprocal downregulation influences cardiac hypertrophic response and progression to heart failure: protective role of S1PR1 cardiac gene therapy.

Authors:  Alessandro Cannavo; Giuseppe Rengo; Daniela Liccardo; Gennaro Pagano; Carmela Zincarelli; Maria Carmen De Angelis; Roberto Puglia; Elisa Di Pietro; Joseph E Rabinowitz; Maria Vittoria Barone; Plinio Cirillo; Bruno Trimarco; Timothy M Palmer; Nicola Ferrara; Walter J Koch; Dario Leosco; Antonio Rapacciuolo
Journal:  Circulation       Date:  2013-08-22       Impact factor: 29.690

4.  Coexpression of human somatostatin receptor-2 (SSTR2) and SSTR3 modulates antiproliferative signaling and apoptosis.

Authors:  Sajad A War; Ujendra Kumar
Journal:  J Mol Signal       Date:  2012-05-31

5.  Pathophysiology of GPCR Homo- and Heterodimerization: Special Emphasis on Somatostatin Receptors.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  Pharmaceuticals (Basel)       Date:  2012-04-27

6.  Heterodimerization of β2 adrenergic receptor and somatostatin receptor 5: Implications in modulation of signaling pathway.

Authors:  Rishi K Somvanshi; Nicole Chaudhari; Xiaofan Qiu; Ujendra Kumar
Journal:  J Mol Signal       Date:  2011-08-12

7.  δ-opioid receptor and somatostatin receptor-4 heterodimerization: possible implications in modulation of pain associated signaling.

Authors:  Rishi K Somvanshi; Ujendra Kumar
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

Review 8.  Biological and Biochemical Basis of the Differential Efficacy of First and Second Generation Somatostatin Receptor Ligands in Neuroendocrine Neoplasms.

Authors:  Federico Gatto; Federica Barbieri; Marica Arvigo; Stefano Thellung; Jessica Amarù; Manuela Albertelli; Diego Ferone; Tullio Florio
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.